Live feed07:30:00·1077dPRReleasevia QuantisnowXOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology AssetByQuantisnow·Wall Street's wire, on your screen.XOMA· XOMA Royalty CorporationHealth Care
